Dr. Jeffrey Berger

prevention focused cardiologist; platelet scientist; thrombosis & vascular medicine specialist; proud husband & father of fantastic girls; @NYUCVDPrevent

[Dr. Jeffrey Berger @PlateletDoc]

Finally! A circulating platelet genetic signature (PRESS)🔥that predicts platelet hyperreactivity and increased cardiovascular risk. Collaborative science is awesome!! @TessaJBarrett @NSmilowitzMD @NYUCVDPrevent @NYULHCVRC
https://t.co/LMZLuMjABq

[NYU CVD Prevention @NYUCVDPrevent]

Congrats to Dr. Mark Steuerwald our preventive cardiology fellow, on passing the lipid boards (@nationallipid).

Becoming a Diplomate of the American Board of Clinical Lipidology is the highest benchmark of professional competency in Clinical Lipidology.

Well deserved! 👏

[NYU CVD Prevention @NYUCVDPrevent]

📣New in AJPC: AHA #Lipoprotein(a) Discovery Project

Congrats to Dr. Howard Weintraub and colleagues on this publication! This 3 year project was instrumental in developing foundational clinician & patient education resources to advance #LPA awareness.

https://t.co/UInu7jjUum

[Melissa Wong @MelissaWongMD]

Hey, that's @CAPenfield , an outstanding former @OBGYN_CS resident! @mysmfm #SMFM23

[Dr. Jeffrey Berger @PlateletDoc]

Being presented by #MFM specialist Dr Christina Penfield - an outstanding physician scientist - at @MySMFM - exciting ongoing work connecting the link between platelets and adverse pregnancy outcomes #preeclampsia #HDP

[Dr. Jeffrey Berger @PlateletDoc]

Incredible collaboration between #Cardiology and #Obstetrics demonstrating #Platelet hyperreactivity in #pregnancy and risk of ischemic placental disease: The POPPY Study #plateletlab https://t.co/p8Z2heYXQa @ACOGPregnancy @Pregnancy @NYULH_DeptofMed @nyulangone @NYUCVDPrevent

[NYU CVD Prevention @NYUCVDPrevent]

🗞️Now on @JCI_insight! Monocyte #platelet aggregates (MPA) emerges as a biomarker of thromboinflammation. TIPS, a platelet RNA signature, captures thromboinflammation and holds promise for cardiovascular risk stratification and therapeutic targeting.

https://t.co/ruQxoFXtjW

[Dr. Jeffrey Berger @PlateletDoc]

Finally - a #platelet genetic signature (TIPS)🔥of #thromboinflammation and increased cardiovascular risk. Collaborative science is awesome!! https://t.co/Us7nQ1pbrl
@TessaJBarrett
@garshick
@NYUCVDPrevent
@NYULHCVRC @JCI_insight

[NYU CVD Prevention @NYUCVDPrevent]

Why are #PCSK9 inhibitors still underutilized?

Join leading lipid expert Dr. James Underberg to explore how PCSK9 inhibitors can help patients with ASCVD, HeFH, & HoFH #knowFH achieve LDL-C goals that have remained out of reach with standard therapies.

🔗https://t.co/Cr3AAx5Hvt

[NYU CVD Prevention @NYUCVDPrevent]

📢 Don’t miss this CME! Join us on Dec 4 (NYC/online), to hear #CKM health expert Chiadi Ndumele, MD, PhD, MHS, discuss optimal strategies for enhancing cardiovascular-kidney-metabolic health.

Save your seat: https://t.co/Cr3AAx5Hvt

Jointly provided @nyugrossman & @NewYorkACP

[NYU CVD Prevention @NYUCVDPrevent]

📰Now available via @ScienceAdvances!

Our investigators and colleagues report on work that identifies the mechanism of platelet-induced mitochondrial dysfunction in myocardial dysfunction
@plateletdoc

➡️https://t.co/7oFrUrR1IW

[Dr. Jeffrey Berger @PlateletDoc]

Thank you @ScienceAdvances for publishing our collaborative effort demonstrating how #Platelets induce vascular dysfunction in myocardial infarction @JoshuaBeckmanMD @TessaJBarrett @smilowitz @NYUCVDPrevent @NYULHCVRC https://t.co/9T5T7DcyjZ

[NYU CVD Prevention @NYUCVDPrevent]

Personalized #CVD prevention is on the horizon!

Today at #AHA25 (1:59-2:04pm), Dr. Carine Hamo will share details about PROSPER, a circulating plasma protein signature that identifies heightened platelet activity & predicts CVD risk.

Pop Sci Zone
Mod Dig Poster 10
AI.MDP.23

[NYU CVD Prevention @NYUCVDPrevent]

How does aggressive #lipid lowering affect vascular endothelium in #diabetic vs healthy individuals?

➡️Sun, 11/9 (11:50-11:55 AM) at #AHA25

Stop by moderated digital poster 13 (PL.MDP.09) to hear findings from the Cardiometabolic Health Strategically Focused Research Network.

[Glenn Fishman @glennfishman]

NYU Cardiology is having a major presence at the AHA Scientific Sessions and everyone came out to celebrate Judith Hochman receiving the Research Achievement Award.

[NYU CVD Prevention @NYUCVDPrevent]

How do statins enhance endothelial health & reduce #inflammation?

Dr. Michael Garshick will present important findings from the Cardiometabolic Health Strategically Focused Research Network.

Mon, 11/10, 11:06-11:11 AM
Basic Sci Zone
Moderated Digital Poster 26: VB.MDP.16

[NYU CVD Prevention @NYUCVDPrevent]

Carine Hamo reports on premature discontinuation or downtitration of #heartfailure GDMT after changes in kidney function at #AHA25.

Fear of mild eGFR declines (<30%) may limit life-saving HF therapies despite their known benefits.

🗝️Tackling prescriber hesitation is key!

[NYU CVD Prevention @NYUCVDPrevent]

New findings suggest 7,000 steps may be enough to reduce your risk of heart disease & stroke. Focus on moving more & sitting less, & activities you love, like gardening or dancing says our Director of Cardiovascular Fitness & Nutrition, Dr. Sean Heffron.
https://t.co/rBI3ZJi584

[Dr. Jeffrey Berger @PlateletDoc]

Platelet reactivity expression score (PRESS) is increased in #diabetes and identifies pts at higher risk of cardiovascular events @JoshuaBeckmanMD @NYULHCVRC https://t.co/zxY6OZC6Nl

[Dr. Jeffrey Berger @PlateletDoc]

@AWeinstock Congratulations!!

[NYU CVD Prevention @NYUCVDPrevent]

📣New Research Alert! Patients with both PAD and #diabetes are more likely to have hyperreactive #platelets, as measured by the PRESS genetic signature, putting them at higher risk for cardiovascular events.

Open Access: https://t.co/n154wfPA0Z